A carregar...

Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.

The relatively restricted use of hormone replacement therapy in the United Kingdom has frequently been noted. It is possible that low prescribing rates may, in part, be due to the difficulty in interpreting the wealth of research evidence relating to the risks and benefits of hormone replacement the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Goddard, M K
Formato: Artigo
Idioma:Inglês
Publicado em: 1992
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1371997/
https://ncbi.nlm.nih.gov/pubmed/1493029
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!